High mobility group box 1 protein interacts with multiple Toll-like receptors

被引:764
|
作者
Park, JS
Gamboni-Robertson, F
He, QB
Svetkauskaite, D
Kim, JY
Strassheim, D
Sohn, JW
Yamada, S
Maruyama, I
Banerjee, A
Ishizaka, A
Abraham, E
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80262 USA
[3] Shino Test Corp, Kanagawa, Japan
[4] Kagoshima Univ, Grad Sch Med Sci & Dent Sci, Kagoshima 890, Japan
[5] Keio Univ, Sch Med, Dept Med, Tokyo 160, Japan
来源
关键词
fluorescence resonance energy transfer; receptor of advanced glycation end products;
D O I
10.1152/ajpcell.00401.2005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
High mobility group box 1 (HMGB1), originally described as a DNA-binding protein, can also be released extracellularly and functions as a late mediator of inflammatory responses. Although recent reports have indicated that the receptor for advanced glycation end products ( RAGE) as well as Toll-like receptor (TLR)2 and TLR4 are involved in cellular activation by HMGB1, there has been little evidence of direct association between HMGB1 and these receptors. To examine this issue, we used fluorescence resonance energy transfer (FRET) and immunoprecipitation to directly investigate cell surface interactions of HMGB1 with TLR2, TLR4, and RAGE. FRET images in RAW264.7 macrophages demonstrated association of HMGB1 with TLR2 and TLR4 but not RAGE. Transient transfections into human embryonic kidney-293 cells showed that HMGB1 induced cellular activation and NF-B-K-dependent transcription through TLR2 or TLR4 but not RAGE. Coimmunoprecipitation also found interaction between HMGB1 and TLR2 as well as TLR4, but not with RAGE. These studies provide the first direct evidence that HMGB1 can interact with both TLR2 and TLR4 and also supply an explanation for the ability of HMGB1 to induce cellular activation and generate inflammatory responses that are similar to those initiated by LPS.
引用
收藏
页码:C917 / C924
页数:8
相关论文
共 50 条
  • [41] Toll-like receptors
    Lien, E
    Ingalls, RR
    CRITICAL CARE MEDICINE, 2002, 30 (01) : S1 - S11
  • [42] Toll-Like Receptors
    Kundakci, Aycan
    Pirat, Arash
    JOURNAL OF THE TURKISH SOCIETY OF INTENSIVE CARE-TURK YOGUN BAKM DERNEGI DERGISI, 2012, 10 (02): : 63 - 73
  • [43] Signaling of High Mobility Group Box 1 (HMGB1) through Toll-like Receptor 4 in Macrophages Requires CD14
    Kim, Sodam
    Kim, Sun Young
    Pribis, John P.
    Lotze, Michael
    Mollen, Kevin P.
    Shapiro, Richard
    Loughran, Patricia
    Scott, Melanie J.
    Billiar, Timothy R.
    MOLECULAR MEDICINE, 2013, 19 : 88 - 98
  • [44] Signaling of High Mobility Group Box 1 (HMGB1) through Toll-like Receptor 4 in Macrophages Requires CD14
    Sodam Kim
    Sun Young Kim
    John P. Pribis
    Michael Lotze
    Kevin P. Mollen
    Richard Shapiro
    Patricia Loughran
    Melanie J. Scott
    Timothy R. Billiar
    Molecular Medicine, 2013, 19 : 88 - 98
  • [45] High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer
    Yue, Yanqiu
    Zhou, Tao
    Gao, Yanjing
    Zhang, Zongli
    Li, Li
    Liu, Lin
    Shi, Wenna
    Su, Lihui
    Cheng, Baoquan
    TUMOR BIOLOGY, 2017, 39 (03)
  • [46] Toll-Like Receptor 4 and High-Mobility Group Box 1 Are Critical Mediators of Tissue Injury and Survival in a Mouse Model for Heatstroke
    Dehbi, Mohammed
    Uzzaman, Taher
    Baturcam, Engin
    Eldali, Abdelmoneim
    Ventura, Wilhelmina
    Bouchama, Abderrezak
    PLOS ONE, 2012, 7 (09):
  • [47] High mobility group box 1 enhances Toll-like receptor 9 expression in B cells in myeloperoxidase-ANCA-associated vasculitis
    Deng, H.
    Wang, C.
    Gong, Y.
    You, R.
    Chen, M.
    Zhao, M. -H
    Wu, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 324 - 325
  • [48] Cardiopulmonary Bypass Induces Acute Lung Injury via the High-Mobility Group Box 1/Toll-Like Receptor 4 Pathway
    Deng, Yuxiao
    Hou, Lei
    Xu, Qiaoyi
    Liu, Qi
    Pan, Su
    Gao, Yuan
    Dixon, Richard A. F.
    He, Zhengyu
    Wang, Xiangrui
    DISEASE MARKERS, 2020, 2020
  • [49] The multiple facets of toll-like receptors in transplantation biology
    Alegre, Maria-Luisa
    Leemans, Jaklien
    Le Moine, Alain
    Florquin, Sandrine
    De Wilde, Virginie
    Chong, Anita
    Goldman, Michel
    TRANSPLANTATION, 2008, 86 (01) : 1 - 9
  • [50] Exploiting Toll-Like receptors for designed multiple ligands
    Mbow, ML
    Sarisky, RT
    DRUG DISCOVERY TODAY, 2004, 9 (24) : 1038 - 1039